Contact
QR code for the current URL

Press release Box-ID: 1002655

ibidi GmbH Lochhamer Schlag 11 82166 Gräfelfing bei München, Germany http://www.ibidi.de
Contact ibidi GmbH +49 89 52046170
Company logo of ibidi GmbH

ibidi Supports Virology Research Worldwide

(PresseBox) ( Munich, Germany, )
In the current urgency to develop vaccines against virus-related diseases, academic institutes and biopharmaceutical companies worldwide rely on the broad product portfolio offered by ibidi. Many publications in reputable scientific journals reflect the importance of ibidi’s ongoing contribution to this research area.

The COVID-19 pandemic, caused by the highly pathogenic SARS-CoV-2 virus, is spreading quickly. Scientists all over the world are intensively working to find solutions to fight this and other viruses—from pathogen detection through therapeutics, to the development of novel vaccines.

For more than 18 years, ibidi has been helping in many areas of virology research, resulting in hundreds of virology-related publications citing ibidi solutions. Researchers can refer to the ibidi Publication Database at ibidi.com to find references for their specific scientific work.

“The research of specific antiviral treatments is urgently needed, and we are working hard to help researchers worldwide advance their therapeutic solutions,” says Dr. Roman Zantl, CEO at ibidi. “If you need a specialized product for your research that is not in our portfolio, please contact us and we will gladly collaborate with you.”

Please find further information on how ibidi supports virus research and about collaboration possibilities at ibidi.com/virology.

ibidi GmbH

ibidi® GmbH, located in Gräfelfing near Munich, Germany, is a leading supplier of functional cell-based assays and products for cell microscopy. The ibidi range of products offers solutions for classic cell culturing, and also complex assays (e.g., angiogenesis, chemotaxis, and wound healing). Their products help facilitate an understanding of the development of various diseases and related therapies. ibidi’s customers are working in scientific institutions, industrial pharmacology, and biotechnology. Technology development at ibidi is supported by the BMBF (Bundesministerium für Bildung und Forschung). The products are sold to customers worldwide.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.